Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative Review.
Journal of Consulting and Clinical PsychologyPublished 1 January 1997
Jonathan S. Abramowitz
Citations489
SJR quartileQ1
SJR score2.23
SNIP2.00
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Quantitative review of the controlled treatment outcome literature for obsessive-compulsive disorder showed that exposure with response prevention was highly effective in reducing OCD symptoms and cognitive approaches were also found to be at least as effective as exposure procedures.
Abstract
Quantitative review of the controlled treatment outcome literature for obsessive-compulsive disorder (OCD) showed that exposure with response prevention was highly effective in reducing OCD symptoms. Cognitive approaches were also found to be at least as effective as exposure procedures. It appears that both cognitive and exposure interventions involve some overlapping procedures and capitalize on similar mechanisms of change. Serotonergic medication, particularly clomipramine, also substantially reduced OCD symptoms. However, clomipramine may not be particularly superior to other serotonergic medication. The relationship between side effects and effect size in medication trials was explored.
Keywords
PsychologyNeuroscience
Encyclopedia of Social WorkDiagnostic and Statistical Manual of Mental Disorders
109,983 Citations2013Janet B. W. Williams, Michael B. First
Computers Environment and Urban SystemsStatistical power analysis for the behavioral sciences
65,645 Citations1990
Archives of General PsychiatryThe Yale-Brown Obsessive Compulsive Scale
7,464 Citations1989Wayne K. Goodman
In a study involving four raters and 40 patients with obsessive-compulsive disorder at various stages of treatment, interrater reliability for the total Yale-Brown Scale score and each of the 10 individual items was excellent, with high degree of internal consistency among all item scores demonstrated with Cronbach's alpha coefficient.
Cognitive Therapy and the Emotional Disorders
6,314 Citations1975Aaron T. Beck
Psychological BulletinEmotional processing of fear: Exposure to corrective information.
5,263 Citations1986Edna B. Foa, Michael J. Kozak
Mechanisms that govern the processing of emotional information, particularly those involved in fear reduction, are proposed and applications to therapeutic practice and to the broader study of psychopathology are discussed.
Behaviour Research and TherapyObsessional-compulsive problems: A cognitive-behavioural analysis
1,813 Citations1985Paul M. Šalkovskis
A close examination of cognitive and behavioural models leads to the suggestion that intrusive thoughts are best regarded as cognitive stimuli rather than responses, and a cognitive-behavioural model based on this view is outlined and illustrated by clinical material derived from a case series.
American PsychologistThe efficacy of psychological, educational, and behavioral treatment: Confirmation from meta-analysis.
1,598 Citations1993Mark W. Lipsey, David B. Wilson
Although meta-analysis has limitations, there are good reasons to believe that its results are more credible than those of conventional reviews and to conclude that well-developed psychological, educational, and behavioral treatment is generally efficacious.
Archives of General PsychiatryThe Epidemiology of Obsessive-Compulsive Disorder in Five US Communities
1,349 Citations1988Marvin Karno
The prevalence of obsessive-compulsive disorder was measured in five US communities among more than 18,500 persons in residential settings as part of the National Institute of Mental Health--sponsored Epidemiologic Catchment Area program, finding rates about 25 to 60 times greater than had been estimated on the basis of previous studies of clinical populations.
American Journal of PsychiatryClinical characteristics and family history in DSM-III obsessive- compulsive disorder
670 Citations1986Steven A. Rasmussen, Ming T. Tsuang
The authors present the clinical characteristics, demographic features, and family history of a clinical sample of 44 patients who met DSM-III criteria for obsessive-compulsive disorder, which should prove useful in further epidemiologic, biologic, and behavioral studies.
Behaviour Research and TherapyCognitive-behavioural factors and the persistence of intrusive thoughts in obsessional problems
599 Citations1989Paul M. Šalkovskis
The current form of the hypothesis is outlined and recent data reviewed, and possible experimental investigations on the focus of therapeutic interventions are considered.
Archives of General PsychiatryHaloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder
569 Citations1994Christopher J. McDougle
The results of this study suggest that OCD patients with a comorbid chronic tic disorder constitute a clinically meaningful subtype of OCD that might require conjoint serotonin-uptake inhibitor/neuroleptic therapy for effective symptom reduction.
Archives of General PsychiatryClomipramine Treatment of Obsessive-Compulsive Disorder
494 Citations1980Peter Thorén
Clomipramine, but not nortriptyline, was superior to placebo in interview-based ratings of severity of OCD, and the effect was not clear-cut until after five weeks of treatment.
Behavior TherapyCognitive behavioral versus exposure only treatment for social phobia: A meta-analysis
448 Citations1995Ulrike Feske, Dianne L. Chambless
Biological PsychiatryObsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology
413 Citations1987Joseph Zohar, Thomas R. Insel
The results demonstrate that agents that bind to the 5HT-1 receptor can acutely affect the symptoms of OCD patients and suggest that serotonergic neurons may play a role in the pathophysiology, as well as mediating the pharmacological reduction, of obsessional symptoms.
Archives of General PsychiatryEfficacy of Fluvoxamine in Obsessive-Compulsive Disorder
390 Citations1989Wayne K. Goodman
A six- to eight-week double-blind placebo-controlled trial of the potent and selective serotonin reuptake inhibitor fluvoxamine was conducted in 42 patients with primary obsessive-compulsive disorder, lending partial support to the serotonin hypothesis of OCD.
Archives of General PsychiatryClomipramine in the Treatment of Patients With Obsessive-Compulsive Disorder
390 Citations1991
Clomipramine was generally well tolerated and was effective in reducing obsessive and compulsive symptoms and was superior on the basis of the physicians' and patients' evaluations of global therapeutic change.
Behaviour Research and TherapyCognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder
350 Citations1995Patricia van Oppen, Else de Haan +4 more
The results show that this form of cognitive therapy is an effective treatment for OCD and suggest that cognitive therapy may be even more effective than exposure in vivo.
Biological PsychiatryObsessive-compulsive disorder and serotonin: Is there a connection?
340 Citations1985Thomas R. Insel, Edward A. Mueller +3 more
It is demonstrated that pharmacological blockade of serotonin reuptake alone is not sufficient for an antiobsessional response.
Archives of General PsychiatryA Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive Disorder
313 Citations1994G.D. Tollefson
Fluoxetine was associated with a statistically significant reduction in OCD severity, including time engaged in obsessional and/or compulsive behaviors, and greater efficacy at 60 mg/d was observed.
Current clinical practiceObsessive Compulsive Disorder
306 Citations2022Robert Hudak, Jessica M. Gannon
Clinical Psychology ReviewA meta-analysis on the treatment of obsessive compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapy
289 Citations1994Anton J.L.M. van Balkom
Treatment results from outcome research on the efficacy of antidepressants, behavior therapy, cognitive therapy, and the combination of these methods in obsessive compulsive disorder indicated that the short-term treatment effects remain stable, and future research on antidepressants and behavior therapy should adopt the same standards for self and assessor-ratings.
The Journal of Nervous and Mental DiseaseA Comparison of Behavioral Group Therapy and Individual Behavior Therapy in Treating Obsessive-Compulsive Disorder
277 Citations1993William Fals‐Stewart, Allen P. Marks +1 more
Both individual and group interventions proved to be equally effective at reducing distress caused by OCD symptoms, general depression, and anxiety by the end of treatment, although patients in the individual behavior therapy condition demonstrated faster reductions in OCD symptom severity.
The British Journal of PsychiatryClomipramine, Self-exposure and Therapist-aided Exposure for Obsessive–Compulsive Rituals
261 Citations1988I. M. Marks, Paul Lelliott +5 more
It is concluded that of the three therapeutic factors tested, self-exposure was the most potent; clomipramine played a limited adjuvant role, and therapist-aided exposure a marginal one.
Behavior TherapyContinuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis
256 Citations1978Edna B. Foa, Alan J. Goldstein
Twenty-one obsessive-compulsive patients were treated by continuous exposure to discomfort-evoking stimuli and complete prevention of discomfort-reducing rituals and a marked improvement was observed after therapy and at follow-up.
Biological PsychiatryClomipramine in obsessive-compulsive disorder
241 Citations1990Richard J. Katz, Joseph DeVeaugh-Geiss +1 more
Findings from the extension study were consistent with continuing efficacy for CMI, whereas corresponding data for patients receiving long-term placebo were difficult to interpret.
Behavior TherapyDeliberate exposure and blocking of obsessive-compulsive rituals: Immediate and long-term effects
234 Citations1984Edna B. Foa, Gail Steketee +3 more
Archives of General PsychiatryControlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive Disorder
221 Citations1990Teresa A. Pigott
Fluoxetine may represent a viable alternative to clomipramine in the treatment of obsessive-compulsive disorder, although further studies with larger sample sizes are needed.
American Journal of PsychiatryFluvoxamine treatment of obsessive-compulsive disorder
213 Citations1987Teri Perse, John H. Greist +3 more
Fluvoxamine treatment was associated with significant improvement on measures of obsessive-compulsive symptoms, anxiety, and depression, and depressed subjects' improvement on obsessive-Compulsive measures correlated with improvement in symptoms of depression.
International Clinical PsychopharmacologyA Controlled Study of Fluvoxamine and Exposure in Obsessive-Compulsive Disorder
204 Citations1990Jean Cottraux, Evelyne Mollard +6 more
All three groups improved in rituals and depression from week 0 to week 24 and 48, with a slight but non-significant superiority for combined treatment up to week24, and the drug superiority was short-lived.
PubMedThe efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
187 Citations1993Christopher J. McDougle, W K Goodman +4 more
Behaviour Research and TherapyCognitive therapy with obsessive-compulsive disorder: A comparative evaluation
177 Citations1991Paul M.G. Emmelkamp, H. Beens
Both treatments resulted in significant improvement on anxiety/discomfort, Maudsley Obsessional Compulsive Inventory, and Dutch Obsession Compulsive Questionnaire and in a reduction of scores on the Irrational Beliefs Test.
Behavior TherapyCurrent status of pharmacological and behavioral treatment of obsessive-compulsive disorder
172 Citations1995Melinda A. Stanley, Samuel M. Turner
Although both drug and behavioral treatments are efficacious, within the confines of limitations in currently available research, it appears that behavioral treatment incorporating exposure (flooding) and response prevention produces the larger response rates, particularly when relapse and drop-out rates are considered.
European NeuropsychopharmacologyA double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder
169 Citations1993S.A. Montgomery
The growing evidence for the safety and efficacy of fluoxetine in the treatment of OCD is supported, with a statistically significant overall difference and a marginally significant difference in the PGI rating of symptom change.
American Journal of PsychiatryA controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory
163 Citations1990M A Jenike, Steven E. Hyman +7 more
Patients with primary obsessive-compulsive disorder participated in a 10-week, double-blind, placebo-controlled trial of the potent, selective serotonin reuptake inhibitor fluvoxamine, finding it significantly better than placebo on two of three measures of improvement in obsessive- compulsive symptoms.
Cognitive Therapy and ResearchCognitive therapy vs exposure in vivo in the treatment of obsessive-compulsives
162 Citations1988Paul M.G. Emmelkamp, S. Visser +1 more
Progress in Neuro-PsychopharmacologyDouble-blind comparative study of clomipramine and amitriptyline in obsessive neurosis
148 Citations1981Jambur Ananth, John C. Pecknold +2 more
The efficacy of clomipramine hydrochloride in severe obsessive compulsive neurosis was compared with that of amitriptyline in a four week randomized double-blind trial and no serious adverse effects were encountered.
The British Journal of PsychiatryAgoraphobia: a Follow-up Study Four Years After Treatment
139 Citations1979Paul M.G. Emmelkamp, Antoinette C. M. Kuipers
No clear relationship was found between external control, social anxiety, depression and duration of the complaint at the beginning of treatment on the one hand and the results at follow-up on the other.
Journal of Consulting and Clinical PsychologyA meta-analysis of antidepressant outcome under "blinder" conditions.
138 Citations1992Roger P. Greenberg, Robert F. Bornstein +2 more
A meta-analysis of 22 studies of antidepressant outcome assessed the level of medication effects under conditions thought to be less subject to clinician bias than those in the typical double-blind drug trial, finding no advantage for antidepressants beyond the placebo effect.
Behaviour Research and TherapyHabituation of subjective anxiety during flooding in imagery
136 Citations1978Edna B. Foa, Dianne L. Chambless
Patterns of habituation of subjective anxiety during flooding in fantasy are delineated for eleven obsessive-compulsive and six agoraphobic patients, with the majority showing a curvilinear pattern, while three patients showed a linear decelerating pattern.
PubMedResults of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
136 Citations1990G Chouinard, Wayne K. Goodman +7 more
Results of the Y-BOCS total score, the NIMH score, and the global severity and improvement scores demonstrated a statistically significant superiority of sertraline compared with placebo.
The Journal of Nervous and Mental DiseaseHow Sound Is the Double-Blind Design for Evaluating Psychotropic Drugs?
125 Citations1993Seymour Fisher, Roger P. Greenberg
The deficiencies of the double-blind paradigm call for a questioning stance with respect to previous studies of psychotropic drug efficacy, and various possible ways of strengthening the double blind paradigm are reviewed.
Psychiatry ResearchClomipramine and imipramine in obsessive-compulsive disorder
122 Citations1985Jan Volavka, Fugen Neziroglu +1 more
The effect of CLI and IMI on OCD was independent of the initial severity of depression, and analyses accounting for the differences in the baseline levels indicated a somewhat superior effect ofcli over IMI over imipramine on OCD as well as depression.
Psychiatric Clinics of North AmericaBehavior Therapy for Obsessive Compulsive Disorder
120 Citations1992Reuven Dar, John H. Greist
Behavior therapy for OCD with exposure and response prevention is effective in reducing obsessions and rituals in at least half of those suffering this disabling disorder.
Psychological AssessmentA computer-administered version of the Yale-Brown Obsessive-Compulsive Scale.
114 Citations1992Rochelle Rosenfeld, Reuven Dar +3 more
American Journal of PsychiatryTricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II
112 Citations1985M Mavissakalian, Samuel M. Turner +2 more
The findings suggest that clomipramine and probably imipramines possess specific antiobsessive effects that are at least partially independent of their antidepressant effects.
American Journal of PsychiatryControlled comparison of buspirone and clomipramine in obsessive- compulsive disorder
108 Citations1991Michele T. Pato, Teresa A. Pigott +4 more
Eighteen outpatients with obsessive-compulsive disorder were treated with either buspirone, a partial serotonin agonist, or clomipramine, a serotonin uptake inhibitor, in a double-blind, random-assignment study and both drugs led to statistically significant and similar improvements in scores on the Yale-Brown Obsessive-Compulsive Rating Scale.
The Journal of Nervous and Mental DiseaseA Meta-Analysis of Fluoxetine Outcome in the Treatment of Depression
105 Citations1994Roger P. Greenberg, Robert F. Bornstein +3 more
Both clinician and patient outcome ratings correlated significantly with the percentage of patients experiencing side effects, and questions are raised about the role of side effects in mediating drug outcome results.
Journal of Anxiety DisordersAge of onset of major subtypes of obsessive—compulsive disorder
95 Citations1990William E. Minichiello, Lee Baer +2 more
In 138 patients with Obsessive Compulsive Disorder, significant differences in mean age of onset were found among subtypes, and patients with obsessions only or cleaning rituals only had comparable ages of onset, while patients with checking rituals only or mixed rituals had earlier onset.
Journal of Clinical PsychopharmacologyClomipramine in Obsessive-Compulsive Disorder
89 Citations1990Matig Mavissakalian, Bruce A. Jones +2 more
Analysis of the clinical significance of pharmacotherapy and the relationship between outcome and plasma drug concentrations in 33 obsessive-compulsive disorder patients treated with clomipramine revealed that 47% of the patients were rated in the subclinical range with one third of the sample being virtually symptom-free.
The British Journal of PsychiatryClomipramine versus Phenelzine in Obsessive–Compulsive Disorder
81 Citations1992J. Vallejo, J. Olivares +3 more
A double-blind clinical trial of clomipramine versus phenelzine was carried out on 30 patients suffering from DSM–III obsessive–compulsive disorder; there was no significant difference between groups.
American Journal of PsychiatryObsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients
78 Citations1989M A Jenike, Lee Baer +4 more
Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.
Journal of Clinical PsychopharmacologyClomipramine versus Fluoxetine in Obsessive-Compulsive Disorder: A Retrospective Comparison of Side Effects and Efficacy
77 Citations1990Michael A. Jenike, Lee Baer +1 more
A meta-analysis of previous studies performed in an attempt to gain some information about comparable efficacy and side effects of these two commonly used agents for the treatment of patients with obsessive-compulsive disorder.
PubMedObsessive-compulsive disorder: a treatment review.
74 Citations1988Teri Perse
For the minority of patients who do not respond to either behavior therapy or medication, psychosurgery--specifically stereotactic limbic leucotomy--should be considered a viable option.
American Journal of PsychiatrySertraline in obsessive-compulsive disorder: a double-blind comparison with placebo [published erratum appears in Am J Psychiatry 1990 Oct;147(10):1393]
72 Citations1990Michael A. Jenike, Lee Baer +4 more
Preliminary findings suggest that sertraline was ineffective according to four measures of obsessive-compulsive symptoms and the need to explore the role of other neurochemical systems in this disorder.
Journal of Clinical PsychopharmacologyA Double-Blind, Placebo Controlled Study of Trazodone
62 Citations1992Teresa A. Pigott, FRANCINE L HEUREUX +4 more
The results indicate that trazodone lacks substantial antiobsessive effects and is associated with only modest reductions in platelet 5-HT concentrations.
PubMedClomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
58 Citations1990John H. Greist, James W. Jefferson +4 more
Clomipramine treatment was associated with statistically significant improvement on several measures of obsessive compulsive symptoms and most patients tolerated clomipramsine well.
Behaviour Research and TherapyA comparison of flooding and thought stopping in the treatment of obsessional neurosis
57 Citations1975Ann Hackmann, Carole McLean
Although both seemed to be effective treatments, there was a slight tendency for flooding to produce more overall improvement, and a greater reduction in avoidance behaviour.
Human Psychopharmacology Clinical and ExperimentalComparison of clomipramine, alprazolam and placebo in the treatment of obsessive—compulsive disorder
57 Citations1992Dan J. Stein, Eric Hollander +3 more
Self‐ratings of obsessive–compulsive symptoms in intent to treat and completer samples demonstrated a significantly greater benefit with CMI than with alprazolam, and ratings of depression and clinician ratings of obsessionality did not indicate differences between the treatment groups.
PubMedClinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
47 Citations1990Joseph DeVeaugh-Geiss, Richard J. Katz +3 more
The overall conclusion from this analysis is that none of the variables studied is a reliable predictor of responses to treatment with CMI, and male patients and patients with a longer duration of illness may be less likely to respond to CMI treatment.
Annals of Clinical PsychiatryShort- and Long-Term Treatment of Obsessive-Compulsive Disorder with Fluvoxamine
41 Citations1992Gopinath Mallya, K. Geoffrey White +2 more
Analysis of the chane scores on the Yale-Brown Scale for O&D show significantly greater improvement with fluvoxamine than with placebo, but the frequency and rapidity of relapse even after prolonged treatment is a concern.